Restricted accessResearch articleFirst published online 2019-07-02
Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer’s Disease Cerebrospinal Fluid Biomarker Levels
We investigated a sample of cognitively healthy subjects with normal Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker levels to identify the earliest variables related to longitudinal memory changes.
Objective:
Employing a new highly demanding learning and memory test (the Ancient Farming Equipment Test; AFE-T), we aimed to investigate whether a biomarker related to neurodegeneration (i.e., CSF tau) was associated with longitudinal memory decline.
Methods:
Thirty-two cognitively and biologically normal (CBN) subjects underwent MRI, neuropsychological assessment, and the AFE-T at baseline and 18 months later. To explore the relationship between cognitive performance and relevant factors, a linear model was set up. For a secondary analysis that further explore the effect of tau, the subjects were divided into CBN-Tau↓ (tau < 228.64 pg/ml; n = 16) and CBN-Tau↑ (tau > 228.64 pg/ml; n = 16). We also performed voxel-based morphometry (VBM) to identify regions of grey matter volume that would predict both baseline and longitudinal cognitive performance.
Results:
Our main finding was an association between CSF tau and longitudinal memory decline measured with AFE-T (B = –0.17, p < 0.05; r = –0.414; p < 0.01), and further analyses showed different evolvement between subgroups, with an accelerated decline in individuals with higher tau (F(1,31) = 8.37; p < 0.01). VBM results suggested that AFE-T performance is related to grey matter volume in a medial temporal, middle frontal, and posterior cerebellar network at baseline, and that there are strategic brain areas driving the longitudinal cognitive changes.
Conclusions:
The present findings provide evidence for structural and biological markers linked to cognitive aging by highlighting the role of tau, a marker of neurodegeneration, which can be related with the earliest memory changes in healthy subjects.
FjellAM, McEvoyL, HollandD, DaleAM, WalhovdKB (2014) What is normal in normal aging? Effects of aging, amyloid and Alzheimer’s disease on the cerebral cortex and the hippocampus. Prog Neurobiol117, 20–40.
NybergL, MaitlandSB, RönnlundM, BäckmanL, DixonRA, WahlinÅ, NilssonL-G (2003) Selective adult age differences in an age-invariant multifactor model of declarative memory. Psychol Aging18, 149–160.
4.
KawasC, GrayS, BrookmeyerR, FozardJ, ZondermanA (2000) Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology54, 2072–2077.
RentzDM, AmariglioRE, BeckerJA, FreyM, OlsonLE, FrisheK, CarmasinJ, MayeJE, JohnsonKA, SperlingRA (2011) Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia49, 2776–2783.
15.
AmariglioRE, FrisheK, OlsonLE, WadsworthLP, LoriusN, SperlingRA, RentzDM (2012) Validation of the Face Name Associative Memory Exam in cognitively normal older individuals. J Clin Exp Neuropsychol34, 580–587.
16.
AlegretM, ValeroS, OrtegaG, EspinosaA, SanabriaA, HernándezI, RodríguezO, Rosende-RocaM, MauleónA, VargasL, MartínE, RuízA, TárragaL, AmariglioRE, RentzDM, BoadaM (2015) Validation of the Spanish version of the Face Name Associative Memory Exam (S-FNAME) in cognitively normal older individuals. Arch Clin Neuropsychol30, 712–720.
17.
ParraMA, AbrahamsS, LogieRH, MéndezLG, LoperaF, Della SalaS (2010) Visual short-term memory binding deficits in familial Alzheimer’s disease. Brain133, 2702–2713.
18.
LaineM, SalmelinR (2010) Neurocognition of new word learning in the native tongue: Lessons from the ancient farming equipment paradigm. Lang Learn60, 25–44.
19.
CornelissenK, LaineM, RenvallK, SaarinenT, MartinN, SalmelinR (2004) Learning new names for new objects: Cortical effects as measured by magnetoencephalography. Brain Lang89, 617–622.
20.
HulténA, LaaksonenH, VihlaM, LaineM, SalmelinR (2010) Modulation of brain activity after learning predicts long-term memory for words. J Neurosci30, 15160–15164.
21.
GrönholmP, RinneJO, VorobyevVA, LaineM (2007) Neural correlates of naming newly learned objects in MCI. Neuropsychologia45, 2355–2368.
22.
Grönholm-NymanP, RinneJO, LaineM (2010) Learning and forgetting new names and objects in MCI and AD. Neuropsychologia48, 1079–1088.
23.
TuomirantaLM, CàmaraE, Froudist WalshS, RipollésP, SaunavaaraJP, ParkkolaR, MartinN, Rodríguez-FornellsA, LaineM (2015) Hidden word learning capacity through orthography in aphasia. Cortex50, 174–191.
24.
Tort-MerinoA, ValechN, PeñalozaC, Grönholm-NymanP, LeónM, OlivesJ, EstangaA, EcayM, ForteaJ, Martínez-LageP, MolinuevoJL, LaineM, Rodríguez-FornellsA, RamiL (2017) Early detection of learning difficulties when confronted with novel information in preclinical Alzheimer’s disease stage 1. J Alzheimers Dis58, 855–870.
25.
DumurgierJ, HanseeuwBJ, HatlingFB, JudgeKA, SchultzAP, ChhatwalJP, BlackerD, SperlingRA, JohnsonKA, HymanBT, Gómez-IslaT (2017) Alzheimer’s disease biomarkers and future decline in cognitive normal older adults. J Alzheimers Dis60, 1451–1459.
26.
HoJK, NationDA (2018) Neuropsychological profiles and trajectories in preclinical Alzheimer’s disease. J Int Neuropsychol Soc24, 693–702.
27.
TijmsBM, VermuntL, ZwanMD, van HartenAC, van der FlierWM, TeunissenCE, ScheltensP, VisserPJ (2018) Pre-amyloid stage of Alzheimer’s disease in cognitively normal individuals. Ann Clin Transl Neurol5, 1037–1047.
28.
PettigrewC, SoldanA, MoghekarA, WangM-C, GrossAL, O’brienR, AlbertM (2015) Relationship between cerebrospinal fluid biomarkers of Alzheimer’s disease and cognition in cognitively normal older adults. Neuropsychologia78, 63–72.
29.
SanabriaA, AlegretM, Rodriguez-GomezO, ValeroS, Sotolongo-GrauÓ, Monté-RubioG, AbdelnourC, EspinosaA, OrtegaG, Perez-CordonA, GailhajanetA, HernandezI, Rosende-RocaM, VargasL, MauleónA, SanchezD, MartinE, RentzDM, LomeñaF, RuizA, TarragaL, BoadaM, FACEHBI study group (2018) The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline. Sci Rep8, 3828.
30.
ValechN, MollicaMA, OlivesJ, TortA, ForteaJ, LleoA, BelénS-S, MolinuevoJL, RamiL (2015) Informants’ perception of subjective cognitive decline helps to discriminate preclinical Alzheimer’s Disease from normal aging. J Alzheimers Dis48, S87–S98.
31.
GroberE, BuschkeH (1987) Genuine memory deficits in dementia. Dev Neuropsychol3, 13–36.
RothC (2011) Boston Diagnostic Aphasia Examination. Encyclopedia of Clinical Neuropsychology. Pearson Canada Assessment Inc., Canada.
34.
WarrigtonE, JamesM (1991) Visual Object and Space Perception battery (VOSP), Thames Valley Test Co, England.
35.
ReitanR (1985) Neuropsychological Test Battery: Theory and clinical interpretation. Neuropsychology Press, USA.
36.
StroopJ (1935) Studies of interference in serial verbal reactions. J Exp Psychol28, 643–662.
37.
SmithA (1968) Symbol Digits Modalities Test. Learning Disorders. Western Psychological Services, Los Angeles.
38.
WechslerD (2008) Wechsler Adult Intelligence Scale (WAIS). Pearson, USA.
39.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
40.
GomarJJ, Ortiz-GilJ, McKennaPJ, SalvadorR, Sans-SansaB, SarróS, GuerreroA, Pomarol-ClotetE (2011) Validation of the Word Accentuation Test (TAP) as a means of estimating premorbid IQ in Spanish speakers. Schizophr Res128, 175–176.
DavisCJ, PereaM (2005) BuscaPalabras: A program for deriving orthographic and phonological neighborhood statistics and other psycholinguistic indices in Spanish. Behav Res Methods37, 665–671.
AshburnerJ (2007) A fast diffeomorphic image registration algorithm. Neuroimage38, 95–113.
45.
AshburnerJ, RidgwayGR (2013) Symmetric diffeomorphic modeling of longitudinal structural MRI. Front Neurosci6, 2–19.
46.
Curran-EverettD, BenosDJ (2004) Guidelines for reporting statistics in journals published by the American Physiological Society. Am J Physiol Regul Integr Comp Physiol287, R247–R249.
DonohueMC, SperlingRA, PetersenR, Chung-KaiS, WeinerMW, AisenPS (2017) Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA317, 2305–2316.
49.
HessenE, NordlundA, StalhammarJ, EckerströmM, BjerkeM, EckerströmC, GöthlinM, FladbyT, ReinvangI, WallinA (2015) T-Tau is associated with objective memory decline over two years in persons seeking help for subjective cognitive decline: A report from the Gothenburg-Oslo MCI study. J Alzheimers Dis47, 619–628.
50.
ThalDR, RübU, OrantesM, BraakH (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology58, 1791–1800.
JessenF, AmariglioRE, van BoxtelM, BretelerM, CeccaldiM, ChételatG, DuboisB, DufouilC, EllisKA, van der FlierWM, GlodzikL, van HartenAC, de LeonMJ, McHughP, MielkeMM, MolinuevoJL, MosconiL, OsorioRS, PerrotinA, PetersenRC, RabinLA, RamiL, ReisbergB, RentzDM, SachdevPS, de la SayetteV, SaykinAJ, ScheltensP, ShulmanMB, SlavinMJ, SperlingRA, StewartR, UspenskayaO, VellasB, VisserPJ, WagnerM (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement10, 844–852.
53.
HassenstabJ, RuvoloD, JasielecM, XiongC, GrantE, MorrisJC (2015) Absence of practice effects in preclinical Alzheimer’s disease. Neuropsychology29, 940–948.
54.
EylerLT, SherzaiA, KaupAR, JesteDV (2011) A review of functional brain imaging correlates of successful cognitive aging. Biol Psychiatry70, 115–122.
GuellX, GabrieliJDE, SchmahmannJD (2018) Triple representation of language, working memory, social and emotion processing in the cerebellum: Convergent evidence from task and seed-based resting-state fMRI analyses in a single large cohort. Neuroimage172, 437–449.
58.
StoodleyCJ, SchmahmannJD (2018) Functional topography of the human cerebellum. Handb Clin Neurol51, 59–70.
59.
RosenbloomMH, SchmahmannJD, PriceBH (2012) The functional neuroanatomy of decision-making. J Neuropsychol Clin Neurosci24, 266–277.
60.
KimSG, UǧurbilK, StrickPL (1994) Activation of a cerebellar output nucleus during cognitive processing. Science265, 949–951.
61.
DesmondJE, FiezJA (1998) Neuroimaging studies of the cerebellum: Language, learning and memory. Trends Cogn Sci2, 355–362.
62.
GoodCD, JohnsrudeIS, AshburnerJ, HensonRNA, FristonKJ, FrackowiakRSJ (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage14, 21–36.
63.
CacciagliaR, MolinuevoJL, Sánchez-BenavidesG, FalcónC, GramuntN, Brugulat-SerratA, GrauO, GispertJD (2018) Episodic memory and executive functions in cognitively healthy individuals display distinct neuroanatomical correlates which are differentially modulated by aging. Hum Brain Mapp39, 4565–4579.
64.
RuscheweyhR, DeppeM, LohmannH, WerschingH, KorsukewitzC, DuningT, BluhmS, StehlingC, KellerSS, KnechtS (2013) Executive performance is related to regional gray matter volume in healthy older individuals. Hum Brain Mapp34, 3333–3346.
65.
RamanoëlS, HoyauE, KauffmannL, RenardF, PichatC, BoudiafN, KrainikA, JaillardA, BaciuM (2018) Gray matter volume and cognitive performance during normal aging. A voxel-based morphometry study. Front Aging Neurosci10, 1–10.
66.
MachuldaMM, PankratzVS, ChristiansonTJ, IvnikRJ, MielkeMM, RobertsRO, KnopmanDS, BoeveBF, PetersenRC (2013) Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic study of aging. Clin Neuropsychol27, 1247–1264.
67.
DodgeHH, WangCN, ChangCCH, GanguliM (2011) Terminal decline and practice effects in older adults without dementia: The MoVIES project. Neurology77, 722–730.
68.
JonaitisEM, KoscikRL, La RueA, JohnsonSC, HermannBP, SagerMA (2015) Aging, Practice effects, and genetic risk in the Wisconsin Registry for Alzheimer’s Prevention. Clin Neuropsychol29, 426–441.
69.
ZehnderAE, BläsiS, BerresM, SpiegelR, MonschAU (2007) Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?Am J Alzheimers Dis Other Demen22, 416–426.
70.
CalamiaM, MarkonK, TranelD (2012) Scoring higher the second time around: Meta-analyses of practice effects in neuropsychological assessment. Clin Neuropsychol26, 543–570.
71.
RentzDM, Parra RodriguezMA, AmariglioR, SternY, SperlingR, FerrisS (2013) Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: A selective review. Alzheimers Res Ther5, 58.
72.
OhH, MadisonC, HaightTJ, MarkleyC, JagustWJ (2012) Effects of age and β-amyloid on cognitive changes in normal elderly people. Neurobiol Aging33, 2746–2755.
